EDP Sciences logo
Rechercher
Menu
Tous les numéros Volume 20 / Numéro 4 (2008) Ann Toxicol Anal, 20 4 (2008) 165-179 Références
Open Access
Numéro
Ann Toxicol Anal
Volume 20, Numéro 4, 2008
Page(s) 165 - 179
DOI https://doi.org/10.1051/ata/2009018
Publié en ligne 19 mars 2009
  1. Malone K, Papagni K, Ramini S, Keltner NL. Antidepressants, antipsychotics, benzodiazepines, and the breastfeeding dyad. Perspect Psychiatr Care. 2004; 40(2): 73–85. [CrossRef] [PubMed] [Google Scholar]
  2. Lambré C. Les risques liés aux contaminants chimiques dans le lait maternel. J Pédiatr Puériculture. 2002; 15: 11–16. [CrossRef] [Google Scholar]
  3. Turck D. Allaitement maternel : les bénéfices pour la santé de l'enfant et de sa mère. Arch Pediatr. 2005; 12: S145–S165. [CrossRef] [PubMed] [Google Scholar]
  4. American Academy of Pediatrics. Breastfeeding and the use of human milk. Work Group on Breastfeeding. Pediatrics. 1997; 100: 1035–1039. [CrossRef] [PubMed] [Google Scholar]
  5. Escobar AMU, Ogawa AR, Hiratsuka M, Kawashita MY, Teruya PY, Grisi S, Tomikawa SO. Aleitamento e condições socioeconômico-culturais: fatores que levam ao desmame precoce. Rev Bras Saude Mater Infant. 2002; 2: 253–261. [CrossRef] [Google Scholar]
  6. Cunningham AS, Jelliffe DB, Jelliffe EF. Breast-feeding and health in the 1980s: a global epidemiologic review. J Pediatr. 1991; 118: 659–666. [CrossRef] [PubMed] [Google Scholar]
  7. Tanaka PA, Yeung DL, Anderson GH. Infant feeding practices: 1984-1985 versus 1977-1978. Can Med Assoc J. 1987; 136: 940–944. [PubMed] [Google Scholar]
  8. Gremmo-Féger G, Dobrzynski M, Collet M. Allaitement maternel et médicaments. J Gynecol Obstet Biol Reprod. 2003; 32: 466–475. [Google Scholar]
  9. Jones W, Brown D. The medication vs. breastfeeding dilemma. Br J Midwifery. 2003; 11: 550–555. [Google Scholar]
  10. Amir LH. Medicines and breastfeeding: information is available on safe use. Med J Aust. 2007; 186(9): 485. [PubMed] [Google Scholar]
  11. Beaufrère B, Bresson JL, Briend A, Ghisolfi J, Goulet O, Navarro J, Putet G, Ricour C, Rieu D, Turck D, Vidailhet M. La promotion de l'allaitement maternel : c'est aussi l'affaire des pédiatres. Arch Pediatr. 2000; 7: 1149–1153. [CrossRef] [PubMed] [Google Scholar]
  12. Newman J. What drugs can I take while breastfeeding? Can J Diagnosis. 1998; 15: 105–120. [Google Scholar]
  13. Howard CR, Lawrence RA. Drugs and breastfeeding. Clin Perinatol 1999; 26: 447–478. [Google Scholar]
  14. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001; 108: 776–789. [PubMed] [Google Scholar]
  15. Lamounier JA, Cabral CM, Oliveira BC, Oliveira AB, Júnior AMO, Silva APA. O uso de medicamentos em puérperas interfere nas recomendações ao aleitamento materno? J Pediatr (Rio J). 2002; 78: 57–61. [Google Scholar]
  16. Lacroix I, Arrault-Olanor A, Berrebi A, Montastruc J-L, Damase-Michel C. Consommation de médicaments en période périnatale : étude comparative chez des femmes allaitant ou non leur enfant. J Pédiatr Puériculture. 2005; 18: 379–385. [CrossRef] [Google Scholar]
  17. Centre national d'information sur le médicament hospitalier. Médicaments et allaitement. Dossier du CNIMH. 1996; XVII(10): 5–6. [Google Scholar]
  18. Matheson I, Kristensen K, Lunde PKM. Drug utilization in breast-feeding women: a survey in Oslo. Eur J Clin Pharmacol. 1990; 38: 453–459. [CrossRef] [PubMed] [Google Scholar]
  19. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993; 168: 1393–1399. [CrossRef] [PubMed] [Google Scholar]
  20. Wisner KL, Peindl KP, Hanusa BH. Relationship of psychiatric illness to childbearing status: a hospital-based epidemiologic study. J Affect Disord. 1993; 28: 39–50. [CrossRef] [PubMed] [Google Scholar]
  21. Patrick MJ, Tilstone WJ, Reavey P. Diazepam and breastfeeding. Lancet. 1972; 1: 542–543. [CrossRef] [Google Scholar]
  22. Erikkola R, Kanto J. Diazepam and breast-feeding. Lancet. 1972; 1: 1235–1236. [CrossRef] [Google Scholar]
  23. Cole AP, Hailey DM. Diazepam and active metabolite in breast milk and their transfer to the neonate. Arch Dis Child. 1975; 50: 741–742. [CrossRef] [PubMed] [Google Scholar]
  24. Dusci LJ, Good SM, Hall RW, Ilett KF. Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam. Br J Clin Pharmacol. 1990; 29: 123–126. [CrossRef] [PubMed] [Google Scholar]
  25. Birnbaum CS, Cohen LS, Bailey JW, Grush LR, Robertson BA, Stowe ZN. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics. 1999; 104(1): e11. [Google Scholar]
  26. Borgatta L, Jenny RW, Gruss L, Ong C, Barad D. Clinical significance of methohexital, meperidine, and diazepam in breast milk. J Clin Pharmacol. 1997; 37(3): 186–192. [CrossRef] [PubMed] [Google Scholar]
  27. Hilbert JM, Gural RP, Symchowicz S, Zamaglione N. Excretion of quazepam into human breast milk. J Clin Pharmacol. 1984; 24(10): 457–462. [CrossRef] [PubMed] [Google Scholar]
  28. Wretlind M. Excretion of oxazepam in breast milk. Eur J Clin Pharmacol. 1987; 33: 209–211. [CrossRef] [PubMed] [Google Scholar]
  29. Matheson I, Lunde PKM, Bredesen JE. Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br J Clin Pharmacol. 1990; 30: 787–793. [CrossRef] [PubMed] [Google Scholar]
  30. Lemmer P, Schneider S, Mühe A, Wennig R. Quantification of lorazepam and lormetazepam in human breast milk using GC-MS in the negative chemical ionozition mode. J Anal Toxicol. 2007; 31: 224–226. [CrossRef] [PubMed] [Google Scholar]
  31. Pons G, Rey E. Passage des médicaments dans le lait. In : Brion F, Cabrol D, Moriette G, Pons G. Les médicaments en périnatologie. Paris : Masson 2003 : 17–26. [Google Scholar]
  32. Neville MC, Allen JC, Watters C. The mechanisms of milk secretion. In : Neville MC, Neifert MR. New York : Lactation editions 1983 : 50. [Google Scholar]
  33. McManaman JL, Neville MC. Mammary physiology and milk secretion. Adv Drug Deliv Rev. 2003; 55: 629–641. [CrossRef] [PubMed] [Google Scholar]
  34. Hale TW. Medications and mothers'milk (10th edition) Amarillo, Tx : Pharmasoft Medical Publishing. 2002 : 266–270. [Google Scholar]
  35. Bavoux F, Warot D. Allaitement et médicament. In : Brion F, Cabrol D, Moriette G, Pons G. Les médicaments en périnatologie. Paris : Masson 2003 : 347–354. [Google Scholar]
  36. Damase-Michel C, Rolland M, Assouline C, Tricoire J, Lacroix I. Médicaments et allaitement maternel. EMC-Médecine. 2004; 1: 417–432. [CrossRef] [Google Scholar]
  37. Lee KG. Lactation and drugs. J Paediatr Child Health. 2007; 17(2): 68–71. [CrossRef] [Google Scholar]
  38. Fleishaker JC, Desai N, McNamara PJ. Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat. J Pharm Sci. 1987; 76: 189–193. [CrossRef] [PubMed] [Google Scholar]
  39. Fleishaker JC, McNamara PJ. In vivo evaluation in the lactating rabbit of a model for xenobiotic distribution into breast milk. J Pharmacol Exp Ther. 1988; 244: 919–924. [PubMed] [Google Scholar]
  40. Fleishaker JC. Models and methods for predicting drug transfer into human milk. Adv Drug Deliv Rev. 2003; 55: 643–652. [CrossRef] [PubMed] [Google Scholar]
  41. Rasmussen F. Mammary excretion of sulphonamides. Acta Pharmacol Toxicol. 1958; 15: 139–148. [CrossRef] [Google Scholar]
  42. Rasmussen F. Mammary excretion of benzylpenicillin, erythromycin, and penethamate hydroiodide. Acta Pharmacol Toxicol. 1959; 16: 194–200. [CrossRef] [Google Scholar]
  43. Rasmussen F. Excretion of drugs by milk, in concepts in biochemical pharmacology. In : Brodie BB, Gillette JR. Berlin : Springer 1971 : 390–402. [Google Scholar]
  44. Oo CY, Kuhn RJ, Desai N, McNamara PJ. Active transport of cimetidine into human milk. Clin Pharmacol Ther. 1995; 58: 548–555. [CrossRef] [PubMed] [Google Scholar]
  45. Gerk PM, Kuhn RJ, Desai NS, McNamara PJ. Active transport of nitrofurantoin into human milk. Pharmacotherapy. 2001; 21: 669–675. [CrossRef] [PubMed] [Google Scholar]
  46. Pons G, Francoual C, Guillet Ph, Moran C, Hermann P, Bianchetti G, Thiercelin JF, Thenot JP, Olive G. Zolpidem excretion in breast milk. Eur J Clin Pharmacol. 1989; 37: 245–248. [CrossRef] [PubMed] [Google Scholar]
  47. Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004; 80: S189–S198. [CrossRef] [PubMed] [Google Scholar]
  48. Wilson JT, Don Brown R, Cherek PR, Dailey JW, Hilman B, Jobe PC, Manno BR. Drug excretion in human breast milk. Principles, pharmacokinetics and projected consequences. Clin Pharmacokinet. 1980; 5: 1–66. [CrossRef] [PubMed] [Google Scholar]
  49. Begg EJ, Duffull SB, Hackett LP, Ilett KF. Studying drugs in human milk: Time to unify the approach. J Hum Lact. 2002; 18: 323–332. [CrossRef] [PubMed] [Google Scholar]
  50. Howard CR, Lawrence RA. Xenobiotics and breastfeeding. Pediatr Clin North Am. 2001; 48: 485–504. [CrossRef] [PubMed] [Google Scholar]
  51. Cregan MD, Hartmann PE. Computerized breast measurement from conception to weaning: clinical implications. J Hum Lact. 1999; 15: 89–96. [CrossRef] [PubMed] [Google Scholar]
  52. De Schuiteneer B, Coninck N. Médicaments et allaitement (2nd edn). Arnette Blackwell, 1996. [Google Scholar]
  53. Belton EM, Jones RV. Haemolytic anaemia due to nalidixic acid. Lancet. 1965; 2: 691. [CrossRef] [PubMed] [Google Scholar]
  54. Varsano I, Fischl J, Shochet SB. The excretion of orally ingested nitrofurantoin in human milk. J Pediatr. 1973; 82: 886–887. [CrossRef] [PubMed] [Google Scholar]
  55. Ito S, Lee A. Drug excretion into breast milk - Overview. Adv Drug Deliv Rev. 2003; 55: 617–627. [CrossRef] [PubMed] [Google Scholar]
  56. Ito S, Koren G. A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol. 1994; 38: 99–102. [CrossRef] [PubMed] [Google Scholar]
  57. Ito S. Drug therapy for breast-feeding women. N Engl J Med. 2000; 343: 118–126. [CrossRef] [PubMed] [Google Scholar]
  58. Wilson JT, Don Brown R, Hinson JL, Dailey JW. Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs. Ann Rev Pharmacol Toxicol. 1985; 25: 667–689. [CrossRef] [Google Scholar]
  59. Larsen LA, Ito S, Koren G. Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother. 2003; 37(9): 1299–1306. [CrossRef] [PubMed] [Google Scholar]
  60. O'Hara MW, Swain AM. Rates and risk of postpartum depression: a meta-analysis. Int Rev Psychiatry. 1996; 8: 37–54. [Google Scholar]
  61. Hagg S, Spigset O. Anticonvulsant use during lactation. Drug Saf. 2000; 22: 425–440. [CrossRef] [PubMed] [Google Scholar]
  62. Deglin JH, Vallerand AH. Davis's drug guide for nurses (8th edn). Philadelphia : Davis, 2003. [Google Scholar]
  63. Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ. Pharmacokinetics in lactating women: Prediction of alprazolam transfer into milk. Br J Clin Pharmacol. 1995; 40: 231–236. [CrossRef] [PubMed] [Google Scholar]
  64. Suri RA, Altshuler LL, Burt VK, Hendrick VC. Managing psychiatric medications in the breast-feeding woman. Medscape Womens Health.1998; 3(1). [Google Scholar]
  65. Nitsun M, Szokol JW, Saleh HJ, Murphy GS, Vender JS, Luong L, Raikoff K, Avram MJ. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clin Pharmacol Ther. 2006; 79(6): 549–557. [CrossRef] [PubMed] [Google Scholar]
  66. Lebedevs TH, Wojnar-Horton RE, Yapp P, Roberts MJ, Dusci LJ, Hackett LP, Ilett KF. Excretion of temazepam in breast milk. Br J Clin Pharmacol. 1992; 33: 204–206. [CrossRef] [PubMed] [Google Scholar]
  67. Humpel M, Stoppelli I, Rainer E. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. Eur J Clin Pharmacol. 1982; 21: 421–425. [CrossRef] [PubMed] [Google Scholar]
  68. Brandt R. Passage of diazepam and N-desmethyldiazepam into breast milk. Arzneim Forsch. 1976; 26: 454–457. [Google Scholar]
  69. Summerfield RJ, Neilsen MS. Excretion of lorazepam into breast milk. Br J Anaesth. 1985; 57: 1042–1043. [CrossRef] [PubMed] [Google Scholar]
  70. Soderman P, Matheson I. Clonazepam in breast milk. Eur J Pediatr. 1988; 147: 212–213. [CrossRef] [PubMed] [Google Scholar]
  71. Kanto JH, Aaltonen L, Kangas L, Erkkola R, Pitkanen Y. Placental transfer and breast milk levels of flunitrazepam. Curr Ther Res. 1979; 26: 539–545. [Google Scholar]
  72. Reider J, Wendt G. Pharmacokinetics and metabolism of the hypnotic nitrazepam. In : Garratini S, Mussini E, Randall LO. The benzodiazepines. New York : Raven Press 1973 : 99–127. [Google Scholar]
  73. McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol. 1994; 8(6): 461–475. [CrossRef] [PubMed] [Google Scholar]
  74. Morselli PL, Principi N, Tognoni G, Reali E, Belvedere G, Standen SM, Sereni F. Diazepam elimination in premature and full term infants and children. J Perinat Med. 1973; 1(2): 133–141. [CrossRef] [PubMed] [Google Scholar]
  75. Rane A. Drug metabolism and disposition in infants and children. In: Yaffe SJ, Aranda JV. Neonatal and pediatric pharmacology - therapeutic principles in practice (3rd edn). Philadelphia : Lippincott, Williams & Wilkins 2005 : 32–43. [Google Scholar]
  76. Dencker SJ, Johansson G, Milsom I. Quantification of naturally occurring benzodiazepine-like substances in human breast milk. Psychopharmacology. 1992; 107: 69–72. [CrossRef] [PubMed] [Google Scholar]
  77. Burt V, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E. The use of psychotropic medications during breast-feeding. Am J Psychiatry. 2001; 158: 1001–1009. [CrossRef] [PubMed] [Google Scholar]
  78. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. Bioanalytical method validation - a revisit with decade of progress. Pharm Res. 2000; 17(12): 1551–1557. [CrossRef] [PubMed] [Google Scholar]
  79. Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk. Clinical pharmacokinetic considerations. Clin Pharmacokinet. 1988; 14: 217–240. [CrossRef] [PubMed] [Google Scholar]
  80. VIDAL (http://srv-vidal/medicaments; 6 novembre 2008). [Google Scholar]